Adaptimmune Quarterly report pursuant to Section 13 or 15(d)

Earnings (loss) per share (Tables)

6 Months Ended

Jun. 30, 2016

The following table reconciles the numerator and denominator in the basic and diluted earnings (loss) per share computation (in thousands):

	Three months ended June 30,						Six months ended June 30,
	2016			2015			2016			2015
Numerator for basic and diluted EPS
Net loss	$	(22,095	)	$	(14,568	)	$	(37,671	)	$	(16,513	)
Deemed dividend on convertible preferred shares	—			(2,229		)	—			(8,663		)

Net loss available to ordinary shareholders	$	(22,095	)	$	(16,797	)	$	(37,671	)	$	(25,176	)


Denominator for basic and diluted EPS
Weighted average number of shares used to calculate basic and diluted loss per share	424,711,900			316,559,989			424,711,900			248,222,243